Evaluation of the absolute lymphocyte count as a biomarker for melanoma patients treated with the commercially available dose of ipilimumab (3mg/kg) von Postow, Michael Andrew, Yuan, Jianda, Panageas, Katherine, Bogatch, Kita, Callahan, Margaret, Cheng, Michael, Schroeder, Sebastian Edoardo Artur, Kendle, Ryan F., Harding, James J., Dickson, Mark Andrew, D'Angelo, Sandra P., Carvajal, Richard D., Schwartz, Gary K., Wolchok, Jedd D.

Volltext